GIST - Sutent has been proven

SUTENT results

SUTENT has been proven effective in the treatment of GIST in certain patients

A clinical trial proved that SUTENT is an effective treatment for certain patients with GIST.

4 times the number of months without tumor growth

Patients treated with SUTENT lived 4 times the number of months without tumor growth compared to patients given a placebo.

The data represent a median. SUTENT is not a cure and not all patients will experience the same results.

SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec® (imatinib mesylate) did not stop the cancer from growing, or when you cannot take Gleevec. Gleevec is a registered trademark of Novartis AG.

Section Parent Page: 
Corresponding Section: 
Section Content Type: 
weight: 
4